Comparative Clinical Evaluation of Daily Disposable Lenses in Symptomatic Lens Wearers
- Conditions
- Myopia
- Registration Number
- NCT00953407
- Lead Sponsor
- CIBA VISION
- Brief Summary
The purpose of this trial is to evaluate the extent to which symptoms improve in symptomatic contact lens wearers when fit with one of 5 different daily disposable contact lenses.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 128
- Currently wear spherical, soft contact lenses replaced at intervals of 2 weeks or monthly.
- Habitually wear lenses for at least 8 hours per day, 4 days per week, for at least the past 6 months.
- Report 2 or more qualifying symptoms with current contact lenses with a frequency of "frequently" or "all the time"
- Able to achieve VA of at least 20/40 in each eye with habitual correction and with study lenses at dispense.
- Other protocol inclusion/exclusion criteria may apply.
- Eye injury or surgery within twelve weeks immediately prior to enrollment.
- Currently enrolled in any clinical trial.
- Any use of medications for which contact lens wear could be contraindicated as determined by the investigator.
- History of corneal refractive surgery.
- Cylinder correction greater than 1.00 D.
- Current monovision contact lens wearers.
- Other protocol inclusion/exclusion criteria may apply.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Lens Awareness 4 weeks of wear Lens awareness, as interpreted by the subject, was reported by the subject as a single, retrospective evaluation of 4 week's wear time. Frequency of lens awareness was measured on a 4-point scale, with 1 being never and 4 being all the time. Four-week ratings were compared to baseline ratings, and a negative difference (4-week minus baseline) represented an improvement.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.